TRGOX | VIGRX | TRGOX / VIGRX | |
Total Expense Ratio | 0.70 | 0.17 | 412% |
Annual Report Gross Expense Ratio | 0.75 | 0.17 | 441% |
Fund Existence | 5 years | 32 years | - |
Gain YTD | -6.549 | -8.036 | 81% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 20.6B | 283B | 7% |
Annual Yield % from dividends | 0.00 | 0.39 | - |
Returns for 1 year | 3.84 | 10.20 | 38% |
Returns for 3 years | 17.41 | 28.42 | 61% |
Returns for 5 years | N/A | 151.29 | - |
Returns for 10 years | N/A | 249.99 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LMBS | 49.26 | 0.09 | +0.18% |
First Trust Low Duration Oppos ETF | |||
FTXH | 26.59 | -0.42 | -1.55% |
First Trust Nasdaq Pharmaceuticals ETF | |||
HNDL | 20.77 | -0.33 | -1.56% |
Strategy Shares Nasdaq 7 Handl™ ETF | |||
FITE | 60.51 | -3.69 | -5.75% |
SPDR® S&P Kensho Future Security ETF | |||
TDV | 68.16 | -5.19 | -7.08% |
ProShares S&PTech Div Arstcrts ETF |